Dymon Asia Capital (Singapore)’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History
Bought
Maintained
Sold
Other funds holding SMIH
SLC
GCL
AC
CF
LP
SCM
SCM
Dymon Asia Capital (Singapore)'s SMIH Position: Q4 2022 in Review
Dymon Asia Capital (Singapore) sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q4 2022, closing a stake of 300,000 shares — an estimated $2.95M sold.
Dymon Asia Capital (Singapore) first reported a position in SMIH in Q1 2022 and held it in 3 quarters. The position peaked at $22.8M in Q1 2022. 37 funds tracked by Wall St. Rank hold SMIH as of Q4 2022.
- Dymon Asia Capital (Singapore) reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q4 2022 after selling out during the quarter.
- Dymon Asia Capital (Singapore) sold 300,000 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q4 2022, an estimated $2.95M.
- Dymon Asia Capital (Singapore) first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q1 2022 and held it in 3 quarters.
- Dymon Asia Capital (Singapore)'s Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $22.8M in Q1 2022.
- 37 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q4 2022.
Based on Dymon Asia Capital (Singapore)'s 13F filing for Q4 2022, filed 13 Feb 2023.